REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
05/01/2026
Voltar para busca
Dado oficial do USPTO
NAGAOKA GINSENG-EXTRACT
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
06/01/2026
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 29, 32
Data de depósito
31/10/2019
Data de registro
05/01/2021
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/01/2021
Última transação
06/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
3
Tipo de titular
03
Localização do titular
Nishinomiya-shi, JP
Examinador
O'BRIEN,JENNIFER LYNN
Unidade examinadora
N20
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of six stylized Japanese characters with the wording "NAGAOKA GINSENG-EXTRACT" in a stylized font underneath.
Titulares e representantes
Titulares
NAGAOKA & CO., LTD.
Representantes
David R. Schaffer Miles & Stockbridge P.C.
Classificação técnica
Classes Nice
Classe 5Classe 29Classe 32
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Ginseng dietary supplements in the form of liquidGinseng dietary supplements for humans; dietetic Ginseng beverages adapted for medical purposes; dietetic foodsdrinks and desserts adapted for medical purposes made primarily of Ginseng; pharmaceutical preparations for immunostimulatory activity by enhancing Natural Killer Cell cytotoxicity for human as well as animals including mouse made primarily of Ginseng and pharmaceutical preparations for recovering from exhaustion made primarily of Ginseng
Classe 29
Ginseng extracts for food concentrateprocessed ginseng for use as a concentrated vegetable or root vegetablepreserved ginseng for use as a vegetable or root vegetable; processed vegetables and fruitsprocessed ginseng for use as a vegetable
Classe 32
Drink mixes or juice bases made primarily of ginseng extractsjuice base concentratessyrups for making non-alcoholic beveragessuch as lactic acid bacteria base beverages; carbonated non-alcoholic drinks made primarily of Ginseng; fruit juices made primarily of Ginseng; vegetable juices made primarily of Ginseng; whey beverages bases and mixes made primarily of Ginseng extractssyrups for making whey-based beverages; whey beverages made primarily of Ginseng
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
24/04/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/04/2021
FIMP
FINAL DISPOSITION PROCESSED
06/04/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
05/04/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20/10/2020
PUBO
PUBLISHED FOR OPPOSITION
20/10/2020
GPNX
NOTIFICATION PROCESSED BY IB
18/10/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
30/09/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
30/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
14/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
14/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
14/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
14/09/2020
XAEC
EXAMINER'S AMENDMENT ENTERED
12/09/2020
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/09/2020
GNEA
EXAMINERS AMENDMENT E-MAILED
12/09/2020
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/09/2020
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/09/2020
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
01/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/08/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/08/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
02/06/2020
GNFR
FINAL REFUSAL E-MAILED
02/06/2020
CNFR
FINAL REFUSAL WRITTEN
02/06/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
15/05/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/05/2020
ALIE
ASSIGNED TO LIE
14/05/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/05/2020
RFNT
REFUSAL PROCESSED BY IB
21/03/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/03/2020
RFRR
REFUSAL PROCESSED BY MPU
05/03/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/02/2020
CNRT
NON-FINAL ACTION WRITTEN
12/02/2020
DOCK
ASSIGNED TO EXAMINER
05/02/2020
MAFR
APPLICATION FILING RECEIPT MAILED
18/01/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
14/01/2020
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
13/01/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/01/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NAGAOKA GINSENG-EXTRACT ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.